Literature DB >> 21472492

Regioselective glucuronidation of flavonols by six human UGT1A isoforms.

Baojian Wu1, Beibei Xu, Ming Hu.   

Abstract

PURPOSE: Glucuronidation is a major barrier to flavonoid bioavailability; understanding its regiospecificity and reaction kinetics would greatly enhance our ability to model and predict flavonoid disposition. We aimed to determine the regioselective glucuronidation of four model flavonols using six expressed human UGT1A isoforms (UGT1A1, 1A3, 1A7, 1A8, 1A9, 1A10).
METHODS: In vitro reaction kinetic profiles of six UGT1A-mediated metabolism of four flavonols (all with 7-OH group) were characterized; kinetic parameters (K(m), V(max) and CL(int) = V(max)/K(m)) were determined.
RESULTS: UGT1A1 and 1A3 regioselectively metabolized the 7-OH group, whereas UGT1A7, 1A8, 1A9 and 1A10 preferred to glucuronidate the 3-OH group. UGT1A1 and 1A9 were the most efficient conjugating enzymes with K(m) values of ≤1 μM and relative catalytic efficiency ratios of ≥5.5. Glucuronidation by UGT1As displayed surprisingly strong substrate inhibition. In particular, K(si) values (substrate inhibition constant) were less than 5.4 μM for UGT1A1-mediated metabolism.
CONCLUSION: UGT1A isoforms displayed distinct positional preferences between 3-OH and 7-OH of flavonols. Differentiated kinetic properties between 3-O- and 7-O- glucuronidation suggested that (at least) two distinct binding modes within the catalytic domain were possible. The existence of multiple binding modes should provide better "expert" knowledge to model and predict UGT1A-mediated glucuronidation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21472492      PMCID: PMC3426363          DOI: 10.1007/s11095-011-0418-5

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  37 in total

Review 1.  Beyond eyeballing: fitting models to experimental data.

Authors:  A Christopoulos; M J Lew
Journal:  Crit Rev Biochem Mol Biol       Date:  2000       Impact factor: 8.250

Review 2.  Human UDP-glucuronosyltransferases: metabolism, expression, and disease.

Authors:  R H Tukey; C P Strassburg
Journal:  Annu Rev Pharmacol Toxicol       Date:  2000       Impact factor: 13.820

3.  Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy men.

Authors:  Marjorie G Busby; A Robert Jeffcoat; LeAnne T Bloedon; Matthew A Koch; Tracy Black; Kelly J Dix; William D Heizer; Brian F Thomas; Judith M Hill; James A Crowell; Steven H Zeisel
Journal:  Am J Clin Nutr       Date:  2002-01       Impact factor: 7.045

4.  Identification of the human UDP-glucuronosyltransferases involved in the glucuronidation of combretastatin A-4.

Authors:  Silvio Aprile; Erika Del Grosso; Giorgio Grosa
Journal:  Drug Metab Dispos       Date:  2010-04-07       Impact factor: 3.922

5.  Pharmacophore and quantitative structure activity relationship modelling of UDP-glucuronosyltransferase 1A1 (UGT1A1) substrates.

Authors:  Michael J Sorich; Paul A Smith; Ross A McKinnon; John O Miners
Journal:  Pharmacogenetics       Date:  2002-11

6.  Kinetics of acetaminophen glucuronidation by UDP-glucuronosyltransferases 1A1, 1A6, 1A9 and 2B15. Potential implications in acetaminophen-induced hepatotoxicity.

Authors:  Abdul E Mutlib; Theunis C Goosen; Jonathan N Bauman; J Andrew Williams; Shaila Kulkarni; Seva Kostrubsky
Journal:  Chem Res Toxicol       Date:  2006-05       Impact factor: 3.739

7.  Regioselectivity of phase II metabolism of luteolin and quercetin by UDP-glucuronosyl transferases.

Authors:  Marelle G Boersma; Hester van der Woude; Jan Bogaards; Sjef Boeren; Jacques Vervoort; Nicole H P Cnubben; Marlou L P S van Iersel; Peter J van Bladeren; Ivonne M C M Rietjens
Journal:  Chem Res Toxicol       Date:  2002-05       Impact factor: 3.739

8.  Phase II metabolism of hesperetin by individual UDP-glucuronosyltransferases and sulfotransferases and rat and human tissue samples.

Authors:  Walter Brand; Marelle G Boersma; Hanneke Bik; Elisabeth F Hoek-van den Hil; Jacques Vervoort; Denis Barron; Walter Meinl; Hansruedi Glatt; Gary Williamson; Peter J van Bladeren; Ivonne M C M Rietjens
Journal:  Drug Metab Dispos       Date:  2010-01-07       Impact factor: 3.922

9.  Absorption, Conjugation and Efflux of the Flavonoids, Kaempferol and Galangin, Using the Intestinal CACO-2/TC7 Cell Model.

Authors:  Robert Barrington; Gary Williamson; Richard N Bennett; Barry D Davis; Jennifer S Brodbelt; Paul A Kroon
Journal:  J Funct Foods       Date:  2009-01-01       Impact factor: 4.451

10.  Human udp-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid.

Authors:  Verawan Uchaipichat; Peter I Mackenzie; Xiao-Hui Guo; Dione Gardner-Stephen; Aleksandra Galetin; J Brian Houston; John O Miners
Journal:  Drug Metab Dispos       Date:  2004-04       Impact factor: 3.922

View more
  14 in total

1.  Accurate prediction of glucuronidation of structurally diverse phenolics by human UGT1A9 using combined experimental and in silico approaches.

Authors:  Baojian Wu; Xiaoqiang Wang; Shuxing Zhang; Ming Hu
Journal:  Pharm Res       Date:  2012-06       Impact factor: 4.200

Review 2.  Regioselective sulfation and glucuronidation of phenolics: insights into the structural basis.

Authors:  Baojian Wu; Sumit Basu; Shengnan Meng; Xiaoqiang Wang; Ming Hu
Journal:  Curr Drug Metab       Date:  2011-11       Impact factor: 3.731

Review 3.  Understanding substrate selectivity of human UDP-glucuronosyltransferases through QSAR modeling and analysis of homologous enzymes.

Authors:  Dong Dong; Roland Ako; Ming Hu; Baojian Wu
Journal:  Xenobiotica       Date:  2012-03-02       Impact factor: 1.908

4.  Evaluation of 3,3',4'-trihydroxyflavone and 3,6,4'-trihydroxyflavone (4'-O-glucuronidation) as the in vitro functional markers for hepatic UGT1A1.

Authors:  Baojian Wu; Shuxing Zhang; Ming Hu
Journal:  Mol Pharm       Date:  2011-10-21       Impact factor: 4.939

5.  A new strategy to rapidly evaluate kinetics of glucuronide efflux by breast cancer resistance protein (BCRP/ABCG2).

Authors:  Baojian Wu; Wen Jiang; Taijun Yin; Song Gao; Ming Hu
Journal:  Pharm Res       Date:  2012-07-03       Impact factor: 4.200

6.  Regiospecificity of human UDP-glucuronosyltransferase isoforms in chalcone and flavanone glucuronidation determined by metal complexation and tandem mass spectrometry.

Authors:  Emily D Niemeyer; Jennifer S Brodbelt
Journal:  J Nat Prod       Date:  2013-05-29       Impact factor: 4.050

7.  Identification of flavone glucuronide isomers by metal complexation and tandem mass spectrometry: regioselectivity of uridine 5'-diphosphate-glucuronosyltransferase isozymes in the biotransformation of flavones.

Authors:  Scott A Robotham; Jennifer S Brodbelt
Journal:  J Agric Food Chem       Date:  2013-02-08       Impact factor: 5.279

8.  Disposition of flavonoids via recycling: Direct biliary excretion of enterically or extrahepatically derived flavonoid glucuronides.

Authors:  Min Zeng; Rongjin Sun; Sumit Basu; Yong Ma; Shufan Ge; Taijun Yin; Song Gao; Jun Zhang; Ming Hu
Journal:  Mol Nutr Food Res       Date:  2016-04-13       Impact factor: 5.914

9.  Mutual regioselective inhibition of human UGT1A1-mediated glucuronidation of four flavonoids.

Authors:  Guo Ma; Baojian Wu; Song Gao; Zhen Yang; Yong Ma; Ming Hu
Journal:  Mol Pharm       Date:  2013-07-17       Impact factor: 4.939

10.  Predicting reactivity to drug metabolism: beyond P450s-modelling FMOs and UGTs.

Authors:  Mario Öeren; Peter J Walton; Peter A Hunt; David J Ponting; Matthew D Segall
Journal:  J Comput Aided Mol Des       Date:  2020-06-12       Impact factor: 3.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.